Additional images
See also
Adeno associated virus and gene therapy of the human retina
Charles Schepens – "the father of modern retinal surgery"
Evolution of the eye
Duplex retina
Retinal scan
Retinal vein occlusion
List of xanthoma variants associated with hyperlipoproteinemia subtypes
Rhodopsin
Persistence of vision

References
Further reading
S. Ramón y Cajal, Histologie du Système Nerveux de lHomme et des Vertébrés, Maloine, Paris, 1911. Rodieck RW (1965). "Quantitative analysis of cat retinal ganglion cell response to visual stimuli". Vision Res. 5 (11): 583–601. doi:10.1016/0042-6989(65)90033-7. PMID 5862581. Wandell, Brian A. (1995). Foundations of vision. Sunderland, Mass: Sinauer Associates. ISBN 978-0-87893-853-7. Wässle H, Boycott BB (1991). "Functional architecture of the mammalian retina". Physiol. Rev. 71 (2): 447–480. doi:10.1152/physrev.1991.71.2.447. PMID 2006220. Schulz HL, Goetz T, Kaschkoetoe J, Weber BH (2004). "The Retinome – Defining a reference transcriptome of the adult mammalian retina/retinal pigment epithelium". BMC Genomics (about a transcriptome for eye colour). 5 (1): 50. doi:10.1186/1471-2164-5-50. PMC 512282. PMID 15283859. Dowling, John (2007). "Retina". Scholarpedia. 2 (12): 3487. Bibcode:2007SchpJ...2.3487D. doi:10.4249/scholarpedia.3487. External links
Histology of the Eye, edited by William Krause, Dept. Pathology and Anatomical science, University of Missouri School of Medicine
Eye, Brain, and Vision – online book – by David Hubel
Kolb, H., Fernandez, E., & Nelson, R. (2003). Webvision: The neural organization of the vertebrate retina. Salt Lake City, Utah: John Moran Eye Center, University of Utah. Retrieved 22 July 2014. Demo: Artificial Retina, MIT Technology Review, September 2004. Reports on implant research at Technology Review
Successful photoreceptor transplantation, MIT Technology Review, November 2006.
Randomization was stratified by chemotherapy choice (capecitabine, eribulin, gemcitabine, or vinorelbine), number of lines of therapy in the metastatic setting (≤ 2, > 2), and number of metastatic sites (≤ 2, > 2). The trial was conducted at 166 sites in the United States and 16 other countries.It was approved for medical use in the United States in December 2020. References
External links
"Margetuximab". Drug Information Portal. U.S. National Library of Medicine.